fondaparinux

(redirected from Arixtra)
Also found in: Medical.
Translations

fondaparinux

n fondaparinux m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Its trade name is Arixtra. Its molecular formula is C31H53N3O49S8 and molecular weight is 1508.217 g/mol.
Fondaparinux Market To Show Tremendous Growth Due To Increasing Number of Hip & Knee Surgeries And Rising Heart Infections Diseases Till 2024 / Million Insights
The person is taking blood thinners, such as warfarin (Coumadin), dabigatran (Pradaxa), rivaroxaban (Xarelto), fondaparinux sodium (Arixtra), or aspirin, or has a bleeding disorder.
Nosebleeds Treatment
Resume therapy 24 h after the procedure Factor Xa inhibitors * Fondaparinux (Arixtra) For Fondaparinux, withhold 48 h before the procedure.
Lumbar puncture under fluoroscopy guidance: a technical review for radiologists
Argatroban was stopped; arixtra, 10 mg daily, was started, and monitoring with serial venous duplex ultrasound was continued.
Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism
The first group of patients received thromboprophylaxis with fondaparinux (Arixtra, GlaxoSmithKlineGSK, Brentford, United Kingdom) at a dose of 2.5 mg in subcutaneous injections.
Influence of fondaparinux versus nadroparin calcium thromboprophylaxis on clinical parameters following total knee arthroplasty
Fondaparinux is a generic version of the anticoagulant drag Arixtra. The brand product is approved in the United States and Europe for the treatment of deep vein thrombosis and pulmonary embolism and is also indicated for the prevention of DVT after major surgery, such as knee and hip replacement.
Sales of Dr. Reddy's generic Nexium halted by federal court
Fondaparinux is a generic version of the anticoagulant drug Arixtra. Arixtra is approved in the US and Europe for the treatment of deep vein thrombosis and pulmonary embolism and is also indicated for the prevention of DVT after major surgery, such as knee and hip replacement.
Dr. Reddy's Closes Acquisition off Fondaparinux Intellectual Property
Reddy's Laboratories stated that Fondaparinux is a generic version of the anticoagulant drug Arixtra, which is approved in the US and Europe for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Dr. Reddy's acquires Fondaparinux intellectual property from Alchemia Limited for USD17.5m
Single-dose, prefilled syringes of fondaparinux (2.5 mg/0.5 mL; Arixtra, GlaxoSmithKline, Greenford, United Kingdom), enoxaparin (10 000 anti-Xa IU/mL; Clexane, Sanofi Aventis, Budapest, Hungary) and danaparoid solution (750 anti-Xa IU/0.6 mL; Orgaran, Schering-Plough Corporation, Kenilworth, New Jersey) did not require additional preparation.
Direct thrombin inhibitors and factor Xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant
Reddy's ANDA for Fondaparinux Sodium Injection, a bioequivalent generic version of Arixtra, in the US market by the United States Food and Drug Administration (USFDA).
Dr. Reddy's Laboratories gets USDA approval for Australian bioequivalent sodium injection
You can manage DVT with LMWH--dalteparin (Fragmin), enoxaparin (Lovenox), or tinzaparin (Innohep)--or the factor Xa inhibitor fondaparinux (Arixtra) overlapped with warfarin (Coumadin).
Treating DVT: answers to 7 key questions: complex recommendations for anticoagulant therapy raise questions for family physicians. Here are the evidence-based answers you need to manage DVT patients successfully
Dictionary browser ?
Full browser ?